Onderneming Clover Biopharmaceuticals, Ltd.
Aandelen
2197
KYG2280A1076
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,41 HKD | -1,20% | -2,38% | -33,87% |
27/03 | Clover Biopharmaceuticals vermindert verliezen in 2023 | MT |
26/03 | Clover Biopharmaceuticals, Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 681
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joshua Liang
CEO | Chief Executive Officer | - | 25-12-20 |
Aileen Wang
DFI | Director of Finance/CFO | - | 01-03-21 |
Htay Htay Han
CTO | Chief Tech/Sci/R&D Officer | 56 | 03-02-21 |
Wang Xiaoyan
SEC | Corporate Secretary | - | 31-03-23 |
Lily Yang
HRO | Human Resources Officer | - | 01-05-21 |
Liong Ho Chua
PRN | Corporate Officer/Principal | 60 | 27-04-22 |
Xiao Bing Li
PRN | Corporate Officer/Principal | 56 | 27-07-20 |
Hing Ling Chau
SEC | Corporate Secretary | 49 | 22-12-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Farrow
BRD | Director/Board Member | 62 | 19-04-21 |
Xiao Dong Wang
BRD | Director/Board Member | 61 | 16-03-21 |
Xiao Bin Wu
BRD | Director/Board Member | 62 | 19-04-21 |
Donna Ambrosino
BRD | Director/Board Member | 72 | 17-06-22 |
Ralf Clemens
BRD | Director/Board Member | 71 | 17-06-22 |
Thomas Leggett
BRD | Director/Board Member | 47 | 19-04-21 |
Peng Liang
CHM | Chairman | 63 | 31-10-18 |
Joshua Liang
CEO | Chief Executive Officer | - | 25-12-20 |
Xiang Liao
BRD | Director/Board Member | 59 | 19-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 296 942 929 | 634 503 797 ( 48,92 %) | 0 | 48,92 % |
Bedrijfsgegevens
Clover Biopharmaceuticals Ltd.
49F, Park Place 1598-1601 West Nanjing Road
200010, Shanghai
+
http://www.cloverbiopharma.comSector
Verkoop per regio
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-33,87% | 68,79 mln. | |
+2,77% | 108 mld. | |
+9,78% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,49% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,50% | 16,19 mld. | |
+4,76% | 13,72 mld. | |
+35,22% | 12,22 mld. |
- Beurs
- Aandelen
- Aandeel Clover Biopharmaceuticals, Ltd. - Hong Kong S.E.
- Onderneming Clover Biopharmaceuticals, Ltd.